The purpose of this study is to assess the effectiveness and safety of intraperitoneal
administration of heated nanoliposomal Irinotecan in cytoreductive surgery (CRS), which is
surgery designed to remove as much of the cancer as possible, and heated intraperitoneal
chemotherapy (HIPEC) procedures.
Phase:
Phase 1
Details
Lead Sponsor:
Stony Brook University
Collaborators:
Barbara Ann Karmanos Cancer Institute Ipsen University of Iowa University of Kentucky University of San Diego